A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/2009
12/09/2009	CN100566722C Method and composition for treatment of adenoviral ocular infections
12/09/2009	CN100566711C Compound for the treatment of cancer and use thereof
12/09/2009	CN100566709C Insoluble globin injectable implant
12/08/2009	US7629452 Detecting ligands that stimulate proliferation and/or development of hematopoietic, lymphoid and myeloid cells in vitro and in vivo; expression vectors, cells; IL2 receptors
12/08/2009	US7629446 Nucleic acid molecules encoding a novel ectoparasite saliva protein
12/08/2009	US7629445 Isolated nucleic acid sequence comprising SEQ ID NO: 14 and methods of using said nucleic acid sequence
12/08/2009	US7629441 Feline interferon-alpha proteins
12/08/2009	US7629440 Comprises fusion proteins isolated from influenza virus hemagglutinin and colony stimulating factor
12/08/2009	US7629439 Peptides derived from the protein MMP-2, and the use thereof in antitumoral immunotherapy
12/08/2009	US7629438 Microbiocide for use in treatment and prevention of infection; antitumor agents
12/08/2009	US7629380 Antitumor agents
12/08/2009	US7629330 Use of zwitterionic polysaccharides for the specific modulation of immune processes
12/08/2009	US7629327 Chlamydia 60 Kda CRMP antigens and vaccine uses
12/08/2009	US7629324 Antisense oligonucleotides for treating atopic diseases and neoplastic cell proliferation
12/08/2009	US7629323 Parkinson's disease; central nervous system disorders; reducing activation of Kv3.4 protein
12/08/2009	US7629321 Oligoribonucleotides and ribonucleases for cleaving RNA
12/08/2009	US7629320 Oxyamino-pyrazolo[3,4-d]pyrimidinylribofuranose derivatives, e.g., 1-(2'-C-methyl- beta -D-ribofuranosyl)-4-methoxylamino-pyrazolo[3,4-d]pyrimidine and 1-(2'-C-methyl- beta -D-ribofuranosyl)-3-cyano-4-methoxylamino-pyrazolo[3,4-d]pyrimidine
12/08/2009	US7629319 inhibiting platelet aggregation; for treatment of thrombosis, restenosis, hypertension, heart failure, arrhythmia, inflammation, angina, stroke, atherosclerosis, ischemic conditions, angiogenesis, cancer, and neurodegenerative disorders
12/08/2009	US7629318 Immunosuppressant compounds, methods and uses related thereto
12/08/2009	US7629317 Group of Gastric Antrum Mucosal Proteins that are gastrokines, designated AMP-18. AMP-18 genomic DNA, and cDNA molecules was sequenced for human and mouse, and the protein sequences are predicted from the nucleotide sequences; diagnostic and therapeutic agents for gastrointestinal tract
12/08/2009	US7629316 Method for proliferating natural killer cells
12/08/2009	US7629315 Compositions for blocking the inhibitory effect of human CRP on human leptin
12/08/2009	US7629314 Methods for making proteins containing free cysteine residues
12/08/2009	US7629313 Immunomodulatory polymeric antigens for treating inflammatory pathologies
12/08/2009	US7629311 Methods to facilitate transmission of large molecules across the blood-brain, blood-eye, and blood-nerve barriers
12/08/2009	US7629310 RhoB as a suppressor of cancer cell growth, cell transformation, and metastasis
12/08/2009	US7629309 Targeted therapeutic proteins
12/08/2009	US7629308 Methods relating to muscle selective calcineurin interacting protein (MCIP)
12/08/2009	US7629295 Determination of a specific immunoglobulin using multiple antigens
12/08/2009	US7629163 Methods for producing modified glycoproteins
12/08/2009	US7629149 Polynucleotide encoding an IL-28A polypepide
12/08/2009	US7629148 Polynucleotide encoding an IL-28B polypeptide
12/08/2009	US7629147 PEGylated soluble GP130-dimers useful as a medicament
12/08/2009	US7629146 A nucleic acid molecule that encodes at least one polypeptide useful as antiangiogenic, tumor suppressive and antimigratory agent; inhibits the migration of cultured cells as well as inhibiting angiogenesis, tumor growth, or any other processes that involve the migration of cells in vivo
12/08/2009	US7629145 Expression vector comprising nucleotide sequences coding endothelial growth factor protein for use in prevention and treatment of cell proliferative and eye disorders
12/08/2009	US7629144 Diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with Secs-1 polypeptides
12/08/2009	US7629141 Essential and important genes of Pseudomonas aeruginosa and the use thereof to design or identify antibacterial agents
12/08/2009	US7629135 Toll-like receptor agonists and antagonists and methods of use thereof
12/08/2009	US7629132 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of cancer, apoptosis and autoimmune diseases
12/08/2009	US7629014 Defatted canola flake, protein, and phytate; isoelectric precipitation and/or ultrafiltration
12/08/2009	US7628992 Modification of clostridial toxins for use as transport proteins
12/08/2009	US7628989 Methods of inducing an immune response
12/08/2009	US7628988 Induce cell differentiation; process control
12/08/2009	US7628987 Vectors derived from antibodies for transferring substances into cells
12/08/2009	US7628985 Therapeutic enzyme formulations and uses thereof in celiac sprue and/or dermatitis herpetoformis
12/08/2009	US7628983 treating edema with Kallikrein inhibitor; bovine pancreatic trypsin inhibitor mutants; possibly ecallantide
12/08/2009	US7628978 Stabilized preparations for use in metered dose inhalers
12/08/2009	US7628977 Particles for inhalation having sustained release properties
12/08/2009	CA2540858C Macrocyclic carboxylic acids and acylsulfonamides as inhibitors of hcv replication
12/08/2009	CA2510797C Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/08/2009	CA2461117C Botulinus toxin for treatment of body odour
12/08/2009	CA2404725C Extrusion die
12/08/2009	CA2389025C Hormonal composition based on a progesterone and an oestrogen and use thereof
12/08/2009	CA2359242C Growth differentiation factor inhibitors and uses therefor
12/08/2009	CA2349506C A method for selective expression of therapeutic genes by hyperthermia
12/08/2009	CA2332570C Uses of the borreliacidal epitope(s) of borrelia burgdorferi outer surface protein c (ospc) as vaccine
12/08/2009	CA2322845C Emulsion preconcentrates containing cyclosporin or a macrolide
12/08/2009	CA2302275C Solid solution beadlet
12/08/2009	CA2296742C Method for preparing alkyloxy furanone derivatives, compounds obtained by said method and use of said compounds
12/08/2009	CA2292846C Lh-rh peptide analogues, their uses and pharmaceutical compositions containing them
12/08/2009	CA2292757C Therapeutic, prophylactic and diagnostic agent for cancer, useful for characterizing cancer cells with individual properties
12/08/2009	CA2266584C Inhibition of bcl-2 protein expression by liposomal antisense oligodeoxynucleotides
12/08/2009	CA2263898C Composition and method for repairing neurological tissue
12/08/2009	CA2218116C Pulmonary delivery of aerosolized medicaments
12/08/2009	CA2163012C Anti-egfr single-chain fvs and anti-egfr antibodies
12/08/2009	CA2136871C Composition and method for inducing satiety
12/03/2009	WO2009146463A2 Variant hhip1 protein and methods and uses thereof
12/03/2009	WO2009146207A1 Cripto-1 as a biomarker for chronic inflammatory disease
12/03/2009	WO2009146178A1 Angiogenin and amyotrophic lateral sclerosis
12/03/2009	WO2009145690A1 Method and means for treating viral disease, in particular hiv/aids
12/03/2009	WO2009145489A2 Cell-permeable endostatin recombinant protein, a polynucleotide coated with the same, and an anti-cancer preparation containing the same as an active component
12/03/2009	WO2009145399A1 A composition containing osteopontin for differentiating natural killer cell as an active ingredient and a method of differentiation using thereof
12/03/2009	WO2009144933A1 Apoptosis inducer
12/03/2009	WO2009144739A1 Amorphous daptomycin and a method of purification thereof
12/03/2009	WO2009144577A2 Anionic polyamide functionalized by a tryptophan unit
12/03/2009	WO2009144279A1 Method for the treatment or prophylaxis of chronic inflammatory diseases
12/03/2009	WO2009144038A1 Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of chronic or non-chronic inflammatory digestive diseases
12/03/2009	WO2009144037A1 Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of various diseases
12/03/2009	WO2009143987A1 Viral encoded pellino protein and its uses
12/03/2009	WO2009143865A1 Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of various diseases
12/03/2009	WO2009143864A1 Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of chronic or non-chronic inflammatory digestive diseases
12/03/2009	WO2009143843A1 Indoleamine 2, 3-dioxygenase based immunotherapy
12/03/2009	WO2009143775A1 Anti-hiv vaccines constructed based on amino acid mutation of attenuated live vaccine of eiav
12/03/2009	WO2009143689A1 A soluble tumor necrosis factor receptor mutant
12/03/2009	WO2009143633A1 Pcsk9 inhibitors and methods of use thereof
12/03/2009	WO2009143619A1 Methods of treating or preventing obesity and obesity-related hypertension
12/03/2009	WO2009143610A1 Modulating interstitial pressure and oncolytic viral delivery and distribution
12/03/2009	WO2009143609A1 Method of reducing motility in bacteria by overexpression of a gene of oi-1 genomic island
12/03/2009	WO2009143584A1 Treatment of pulmonary edema
12/03/2009	WO2009143556A1 TREATMENTS FOR EXCITOTOXICITY AND Aß-MEDIATED TOXICITY AND AGE-ASSOCIATED NEURONAL DYSFUNCTION
12/03/2009	WO2009122288A3 Liquid and freeze dried formulations
12/03/2009	WO2009118191A3 Therapy for vitiligo
12/03/2009	WO2009114878A3 Methods and compositions for genetic and retinal disease
12/03/2009	WO2009114623A3 Angiostatic compositions comprising truncated tyrosyl-trna synthetase polypeptides and methods of using same
12/03/2009	WO2009108633A3 Sphingosine 1-phosphate antagonism
12/03/2009	WO2009100456A3 Inhibition and treatment of gastrointestinal biofilms
12/03/2009	WO2009098492A3 Modulation of adenoviral tropism
12/03/2009	WO2009094742A8 Toxin of the spider phoneutria nigriventer for treatment of erectile dysfunction
12/03/2009	WO2009092891A4 Modification of intrinsically disordered sequences for preparing vaccines
12/03/2009	WO2009091994A9 Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses thereof

1 ... 699 700 701 702 703 704 705 706 707 708 709 710 711 712 713 714 715 716 717 718 719 ... 3163